| scholarly article | Q13442814 |
| P2093 | author name string | Qing Chang | |
| Chengzhao Lin | |||
| Shuang Song | |||
| Heyong Wang | |||
| Gentao Liu | |||
| Mingqiang Ren | |||
| Shuang Sha | |||
| Yuanfen Zhai | |||
| P2860 | cites work | Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins? | Q24628819 |
| Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment | Q24656967 | ||
| Notch signaling: an emerging therapeutic target for cancer treatment | Q26784068 | ||
| Induction of cancer stem cell properties in colon cancer cells by defined factors | Q27320228 | ||
| Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells | Q28302950 | ||
| Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties | Q28473512 | ||
| Glycogen synthase kinase 3 beta positively regulates Notch signaling in vascular smooth muscle cells: role in cell proliferation and survival | Q28583993 | ||
| Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds | Q29616608 | ||
| Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data | Q30871677 | ||
| A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog | Q33509682 | ||
| Effect of Gsk3 inhibitor CHIR99021 on aneuploidy levels in rat embryonic stem cells. | Q33775190 | ||
| Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy | Q33829820 | ||
| CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile | Q34170564 | ||
| The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells | Q34200826 | ||
| SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. | Q34269756 | ||
| 3-Deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase, promotes erythroid differentiation | Q34401976 | ||
| Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application | Q34712645 | ||
| The roles of Notch3 on the cell proliferation and apoptosis induced by CHIR99021 in NSCLC cell lines: a functional link between Wnt and Notch signaling pathways | Q35075849 | ||
| EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells | Q35091485 | ||
| 3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells | Q35172602 | ||
| CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition | Q35742418 | ||
| Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail | Q37114711 | ||
| Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells | Q37323067 | ||
| The Lnc RNA SPRY4-IT1 Modulates Trophoblast Cell Invasion and Migration by Affecting the Epithelial-Mesenchymal Transition | Q37419194 | ||
| GSK-3 is a master regulator of neural progenitor homeostasis | Q37670059 | ||
| Cancer stem cells in lung cancer: Evidence and controversies. | Q37709551 | ||
| Therapy-induced enrichment of putative lung cancer stem-like cells. | Q38150766 | ||
| Cancer stem cells: progress and challenges in lung cancer | Q38881450 | ||
| Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines. | Q39023422 | ||
| CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist | Q39033543 | ||
| NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer | Q39227342 | ||
| Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. | Q39247985 | ||
| Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. | Q39619885 | ||
| Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells | Q40086013 | ||
| Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells | Q40433523 | ||
| Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells. | Q40463075 | ||
| Hes1 is involved in the self-renewal and tumourigenicity of stem-like cancer cells in colon cancer | Q41846661 | ||
| SOX2 expression associates with stem cell state in human ovarian carcinoma. | Q46004424 | ||
| Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4. | Q53410584 | ||
| The CD133 expression levels and its role as potential cancer stem cells marker in gastrointestinal stromal tumor | Q59217176 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 53302-53312 | |
| P577 | publication date | 2017-06-07 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | A combination of valproic acid sodium salt, CHIR99021, E-616452, tranylcypromine, and 3-Deazaneplanocin A causes stem cell-like characteristics in cancer cells | |
| P478 | volume | 8 |
| Q58616531 | Novel drug candidates for treating esophageal carcinoma: A study on differentially expressed genes, using connectivity mapping and molecular docking | cites work | P2860 |
Search more.